James M. Ahlers
CIK: 0001320383
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CUE
Cue Biopharma, Inc.
Officer
Discretionary Trading P&L
Holdings
About Ahlers James M
Ahlers James M (SEC CIK 0001320383) files insider reports with the SEC as Chief Financial Officer of Cue Biopharma, Inc. (CUE).
Signal8 holds 2 ownership filings by Ahlers James M (1 Form 3, 1 Form 4), filed on Aug 3, 2026. Those filings report 1 transaction, the latest on Jul 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ahlers James M's filings is in BOSTON, MA.
Recent filings by Ahlers James M
- Jul 30, 2026: Grant or award of CUE shares (Form 4, code A).
Other insiders filing for Cue Biopharma, Inc. (CUE)
- Ray Sumita, Chief Legal Compliance Officer
- Meluzio Michael Vincent, VP, Prin. Accounting Officer
- Lin Shao-Lee, Chief Executive Officer
- Sarraf Pasha, Director
- Garzone Pamela, Director
- Borie Dominique Christian, Chief Medical Officer